David Peel

David Peel, MS, is currently the Director of Regulatory Affairs for Oncology Cell and Gene Therapy at AstraZeneca. With a strong background in regulatory affairs, they have previously held positions as a Senior Regulatory Medical Writer at Emmes and a Regulatory Affairs Consultant at Dunn Regulatory Associates, LLC. David also has experience in research, having worked as an Undergraduate Researcher in Neuroscience at New York University and as an Electron Microscopist at Howard Hughes Medical Institute. They are pursuing a Bachelor of Science in Neuroscience with minors in Chemistry and Psychology at George Mason University. David has earned a Master of Science in Biotechnology with a focus on Regulatory Affairs from the University of Maryland Global Campus.